Michael Pollak - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Cell Biology

187 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hang D, He X, Kværner AS, Chan AT, Wu K, Ogino S, Hu Z, Shen H, Pollak MN, Giovannucci EL, Song M. Plasma Biomarkers of Insulin and the Insulin-like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp. Jnci Cancer Spectrum. 3: pkz056. PMID 32328558 DOI: 10.1093/jncics/pkz056  0.36
2017 Bhat M, Yanagiya A, Graber T, Razumilava N, Bronk S, Zammit D, Zhao Y, Zakaria C, Metrakos P, Pollak M, Sonenberg N, Gores G, Jaramillo M, Morita M, Alain T. Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells. Oncotarget. 8: 50542-50556. PMID 28881582 DOI: 10.18632/Oncotarget.10671  0.56
2017 Hulea L, Cargnello M, Gravel S, Im Y, McLaughlan S, Zhao Y, Ching J, Cai Y, Larsson O, Ohh M, Ursini-Siegel J, St-Pierre J, Pollak M, Topisirovic I. Abstract A31: eIF4F links translation to energy stress response in cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Transcontrol16-A31  0.56
2016 Babic A, Bao Y, Qian ZR, Yuan C, Giovannucci EL, Aschard H, Kraft P, Amundadottir LT, Stolzenberg-Solomon RZ, Morales-Oyarvide V, Ng K, Stampfer MJ, Ogino S, Buring JE, Sesso HD, ... ... Pollak MN, et al. Pancreatic cancer risks associated with prediagnostic plasma levels of leptin and leptin receptor genetic polymorphisms. Cancer Research. PMID 27780823 DOI: 10.1158/0008-5472.Can-16-1699  0.36
2016 Bhat M, Yanagiya A, Graber T, Razumilava N, Bronk S, Zammit D, Zhao Y, Zakaria C, Metrakos P, Pollak M, Sonenberg N, Gores G, Jaramillo M, Morita M, Alain T. Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells. Oncotarget. PMID 27447552 DOI: 10.18632/oncotarget.10671  0.56
2016 Teumer A, Qi Q, Nethander M, Aschard H, Bandinelli S, Beekman M, Berndt SI, Bidlingmaier M, Broer L, Cappola A, Ceda GP, Chanock S, Chen MH, Chen TC, ... ... Pollak MN, et al. Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits. Aging Cell. PMID 27329260 DOI: 10.1111/Acel.12490  0.32
2016 Chapman JW, Sgroi DC, Goss PE, Zarella E, Binns S, Zhang Y, Schnabel CA, Erlander MG, Pritchard KI, Han L, Badovinac-Crnjevic T, Shepherd LE, Pollak MN. Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14. Breast Cancer Research and Treatment. PMID 27116182 DOI: 10.1007/s10549-016-3806-z  0.32
2016 Gandin V, Masvidal L, Hulea L, Gravel SP, Cargnello M, McLaughlan S, Cai Y, Balanathan P, Morita M, Rajakumar A, Furic L, Pollak M, Porco JA, St-Pierre J, Pelletier J, et al. nanoCAGE reveals 5' UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs. Genome Research. PMID 26984228 DOI: 10.1101/Gr.197566.115  0.32
2016 Liu Z, Yokoyama NN, Blair CA, Li X, Avizonis D, Wu XR, Uchio E, Youssef R, McClelland M, Pollak M, Zi X. High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with ∼240-Fold Higher Drug Concentration in Urine than Serum. Molecular Cancer Therapeutics. PMID 26921394 DOI: 10.1158/1535-7163.Mct-15-0714-T  0.6
2016 Hofmann JN, Birmann BM, Teras LR, Pfeiffer RM, Wang Y, Albanes D, Baris D, Colditz GA, De Roos AJ, Giles GG, Hosgood HD, Lan Q, Landgren O, Liao LM, Rothman N, ... ... Pollak MN, et al. Low levels of circulating adiponectin are associated with multiple myeloma risk in overweight and obese individuals. Cancer Research. PMID 26921332 DOI: 10.1158/0008-5472.Can-15-2406  0.32
2016 Travis RC, Appleby PN, Martin RM, Holly JM, Albanes D, Black A, Bueno-de-Mesquita HB, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, ... ... Pollak MN, et al. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Research. 76: 2288-300. PMID 26921328 DOI: 10.1158/0008-5472.Can-15-1551  0.32
2016 Horne HN, Sherman ME, Pfeiffer RM, Figueroa JD, Khodr ZG, Falk RT, Pollak M, Patel DA, Palakal MM, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, et al. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. Breast Cancer Research : Bcr. 18: 24. PMID 26893016 DOI: 10.1186/S13058-016-0678-4  0.32
2016 Aneke-Nash CS, Dominguez-Islas C, Bůžková P, Qi Q, Xue X, Pollak M, Strickler HD, Kaplan RC. Agreement between circulating IGF-I, IGFBP-1 and IGFBP-3 levels measured by current assays versus unavailable assays previously used in epidemiological studies. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 26: 11-6. PMID 26774400 DOI: 10.1016/J.Ghir.2015.12.007  0.32
2016 Inamura K, Song M, Jung S, Nishihara R, Yamauchi M, Lochhead P, Qian ZR, Kim SA, Mima K, Sukawa Y, Masuda A, Imamura Y, Zhang X, Pollak MN, Mantzoros CS, et al. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. Journal of the National Cancer Institute. 108. PMID 26598515 DOI: 10.1093/jnci/djv363  0.32
2015 Iyengar NM, Zhou XK, Gucalp A, Morris PG, Howe LR, Giri D, Morrow M, Wang H, Pollak M, Jones LW, Hudis CA, Dannenberg AJ. Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26712688 DOI: 10.1158/1078-0432.Ccr-15-2239  0.32
2015 Catsburg C, Gunter MJ, Tinker L, Chlebowski RT, Pollak M, Strickler HD, Cote ML, Page DL, Rohan TE. Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast. Journal of Cancer Epidemiology. 2015: 203284. PMID 26106415 DOI: 10.1155/2015/203284  0.32
2015 Stolzenberg-Solomon RZ, Newton CC, Silverman DT, Pollak M, Nogueira LM, Weinstein SJ, Albanes D, Männistö S, Jacobs EJ. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. American Journal of Epidemiology. PMID 26085045 DOI: 10.1093/Aje/Kwv041  0.32
2015 Blouin MJ, Bazile M, Birman E, Zakikhani M, Florianova L, Aleynikova O, Powell DR, Pollak M. Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia. Breast Cancer Research and Treatment. 149: 577-85. PMID 25614235 DOI: 10.1007/S10549-015-3268-8  0.32
2015 Morita M, Gravel SP, Hulea L, Larsson O, Pollak M, St-Pierre J, Topisirovic I. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle (Georgetown, Tex.). 14: 473-80. PMID 25590164 DOI: 10.4161/15384101.2014.991572  0.32
2015 Cao Y, Nimptsch K, Shui IM, Platz EA, Wu K, Pollak MN, Kenfield SA, Stampfer MJ, Giovannucci EL. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. International Journal of Cancer. Journal International Du Cancer. 136: 2418-26. PMID 25348852 DOI: 10.1002/Ijc.29295  0.36
2014 Chapman JA, Pritchard KI, Goss PE, Ingle JN, Muss HB, Dent SF, Vandenberg TA, Findlay B, Gelmon KA, Wilson CF, Shepherd LE, Pollak MN. Competing risks of death in younger and older postmenopausal breast cancer patients. World Journal of Clinical Oncology. 5: 1088-96. PMID 25493245 DOI: 10.5306/wjco.v5.i5.1088  0.32
2014 Gravel SP, Hulea L, Toban N, Birman E, Blouin MJ, Zakikhani M, Zhao Y, Topisirovic I, St-Pierre J, Pollak M. Serine deprivation enhances antineoplastic activity of biguanides. Cancer Research. 74: 7521-33. PMID 25377470 DOI: 10.1158/0008-5472.Can-14-2643-T  0.32
2014 Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, Yuan C, Bao Y, Townsend MK, Tworoger SS, Davidson SM, Papagiannakopoulos T, Yang A, Dayton TL, Ogino S, ... ... Pollak MN, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nature Medicine. 20: 1193-8. PMID 25261994 DOI: 10.1038/Nm.3686  0.36
2014 Jacobs EJ, Newton CC, Silverman DT, Nogueira LM, Albanes D, Männistö S, Pollak M, Stolzenberg-Solomon RZ. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies. Cancer Causes & Control : Ccc. 25: 1083-91. PMID 24913781 DOI: 10.1007/S10552-014-0409-Z  0.32
2014 Beasley JM, Wedick NM, Rajpathak SN, Xue X, Holmes MD, Gunter MJ, Wylie-Rosett J, Rohan TE, Pollak M, Kaplan RC, Hu FB, Sun Q, Strickler HD. Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 24: 142-9. PMID 24888819 DOI: 10.1016/J.Ghir.2014.04.006  0.32
2014 Joshua AM, Zannella VE, Downes MR, Bowes B, Hersey K, Koritzinsky M, Schwab M, Hofmann U, Evans A, van der Kwast T, Trachtenberg J, Finelli A, Fleshner N, Sweet J, Pollak M. A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer. Prostate Cancer and Prostatic Diseases. 17: 252-8. PMID 24861559 DOI: 10.1038/Pcan.2014.20  0.32
2014 Cao Y, Lindström S, Schumacher F, Stevens VL, Albanes D, Berndt S, Boeing H, Bueno-de-Mesquita HB, Canzian F, Chamosa S, Chanock SJ, Diver WR, Gapstur SM, Gaziano JM, Giovannucci EL, ... ... Pollak M, et al. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. Journal of the National Cancer Institute. 106: dju085. PMID 24824313 DOI: 10.1093/Jnci/Dju218  0.32
2014 Lai GY, Giovannucci EL, Pollak MN, Peskoe SB, Stampfer MJ, Willett WC, Platz EA. Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study. Cancer Causes & Control : Ccc. 25: 625-32. PMID 24664287 DOI: 10.1007/S10552-014-0369-3  0.32
2014 de Bono JS, Piulats JM, Pandha HS, Petrylak DP, Saad F, Aparicio LM, Sandhu SK, Fong P, Gillessen S, Hudes GR, Wang T, Scranton J, Pollak MN. Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1925-34. PMID 24536060 DOI: 10.1158/1078-0432.Ccr-13-1869  0.32
2014 Bramwell VH, Tuck AB, Chapman JA, Anborgh PH, Postenka CO, Al-Katib W, Shepherd LE, Han L, Wilson CF, Pritchard KI, Pollak MN, Chambers AF. Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial. Breast Cancer Research : Bcr. 16: R8. PMID 24451146 DOI: 10.1186/bcr3600  0.32
2014 Borugian MJ, Spinelli JJ, Gordon PB, Abanto Z, Brooks-Wilson A, Pollak MN, Warren LJ, Hislop TG, Gallagher RP. Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada). Cancer Causes & Control : Ccc. 25: 385-94. PMID 24435933 DOI: 10.1007/S10552-014-0339-9  0.32
2014 Rothermundt C, Hayoz S, Templeton AJ, Winterhalder R, Strebel RT, Bärtschi D, Pollak M, Lui L, Endt K, Schiess R, Rüschoff JH, Cathomas R, Gillessen S. Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09). European Urology. 66: 468-74. PMID 24412228 DOI: 10.1016/J.Eururo.2013.12.057  0.32
2014 Friedbichler K, Hofmann MH, Kroez M, Ostermann E, Lamche HR, Koessl C, Borges E, Pollak MN, Adolf G, Adam PJ. Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin. Molecular Cancer Therapeutics. 13: 399-409. PMID 24296829 DOI: 10.1158/1535-7163.MCT-13-0598  0.32
2014 Li R, Montpetit A, Rousseau M, Wu SY, Greenwood CM, Spector TD, Pollak M, Polychronakos C, Richards JB. Somatic point mutations occurring early in development: a monozygotic twin study. Journal of Medical Genetics. 51: 28-34. PMID 24123875 DOI: 10.1136/Jmedgenet-2013-101712  0.44
2014 Grimaldi-Bensouda L, Cameron D, Marty M, Barnett AH, Penault-Llorca F, Pollak M, Charbonnel B, Riddle M, Mignot L, Boivin JF, Khachatryan A, Rossignol M, Bénichou J, Alpérovitch A, Abenhaim L, et al. Risk of breast cancer by individual insulin use: an international multicenter study. Diabetes Care. 37: 134-43. PMID 23949559 DOI: 10.2337/Dc13-0695  0.32
2013 Hvid H, Blouin MJ, Birman E, Damgaard J, Poulsen F, Fels JJ, Fledelius C, Hansen BF, Pollak M. Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts. Plos One. 8: e79710. PMID 24260289 DOI: 10.1371/Journal.Pone.0079710  0.32
2013 Morita M, Gravel SP, Chénard V, Sikström K, Zheng L, Alain T, Gandin V, Avizonis D, Arguello M, Zakaria C, McLaughlan S, Nouet Y, Pause A, Pollak M, Gottlieb E, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metabolism. 18: 698-711. PMID 24206664 DOI: 10.1016/J.Cmet.2013.10.001  0.32
2013 Ahern TP, Hankinson SE, Willett WC, Pollak MN, Eliassen AH, Tamimi RM. Plasma C-peptide, mammographic breast density, and risk of invasive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1786-96. PMID 24097198 DOI: 10.1158/1055-9965.EPI-13-0375  0.32
2013 Zu K, Martin NE, Fiorentino M, Flavin R, Lis RT, Sinnott JA, Finn S, Penney KL, Ma J, Fazli L, Gleave ME, Bismar TA, Stampfer MJ, Pollak MN, Loda M, et al. Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1984-93. PMID 23983239 DOI: 10.1158/1055-9965.Epi-13-0349  0.32
2013 Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, et al. Metformin improves healthspan and lifespan in mice. Nature Communications. 4: 2192. PMID 23900241 DOI: 10.1038/Ncomms3192  0.32
2013 Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ, Sato K, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, McTiernan A, Phillips LS, ... ... Pollak MN, et al. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. Journal of the National Cancer Institute. 105: 1027-35. PMID 23847240 DOI: 10.1093/Jnci/Djt123  0.36
2013 Leprivier G, Remke M, Rotblat B, Dubuc A, Mateo AR, Kool M, Agnihotri S, El-Naggar A, Yu B, Somasekharan SP, Faubert B, Bridon G, Tognon CE, Mathers J, Thomas R, ... ... Pollak M, et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell. 153: 1064-79. PMID 23706743 DOI: 10.1016/J.Cell.2013.04.055  0.32
2013 Takahara K, Ibuki N, Ghaffari M, Tearle H, Ong CJ, Azuma H, Gleave ME, Pollak M, Cox ME. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice Prostate Cancer and Prostatic Diseases. 16: 239-247. PMID 23689346 DOI: 10.1038/Pcan.2013.14  0.32
2013 Fendt SM, Bell EL, Keibler MA, Davidson SM, Wirth GJ, Fiske B, Mayers JR, Schwab M, Bellinger G, Csibi A, Patnaik A, Blouin MJ, Cantley LC, Guarente L, Blenis J, ... Pollak MN, et al. Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Research. 73: 4429-38. PMID 23687346 DOI: 10.1158/0008-5472.Can-13-0080  0.32
2013 Palumbo MO, Kavan P, Miller WH, Panasci L, Assouline S, Johnson N, Cohen V, Patenaude F, Pollak M, Jagoe RT, Batist G. Systemic cancer therapy: achievements and challenges that lie ahead. Frontiers in Pharmacology. 4: 57. PMID 23675348 DOI: 10.3389/Fphar.2013.00057  0.32
2013 Moiseeva O, Deschênes-Simard X, Pollak M, Ferbeyre G. Metformin, aging and cancer. Aging. 5: 330-1. PMID 23660016  0.32
2013 Vandersluis AD, Venier NA, Colquhoun AJ, Sugar L, Pollak M, Kiss A, Fleshner NE, Klotz LH, Venkateswaran V. Exercise does not counteract the effects of a "westernized" diet on prostate cancer xenografts. The Prostate. 73: 1223-32. PMID 23630020 DOI: 10.1002/Pros.22673  0.32
2013 Moiseeva O, Deschênes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak MN, Ferbeyre G. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell. 12: 489-98. PMID 23521863 DOI: 10.1111/Acel.12075  0.32
2013 Bao Y, Giovannucci EL, Kraft P, Qian ZR, Wu C, Ogino S, Gaziano JM, Stampfer MJ, Ma J, Buring JE, Sesso HD, Lee IM, Rifai N, Pollak MN, Jiao L, et al. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 855-61. PMID 23462920 DOI: 10.1158/1055-9965.Epi-12-1458  0.36
2013 Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia MS, Hoque A, Hsing AW, Thompson IM, Pollak M. Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 91-9. PMID 23315596 DOI: 10.1158/1940-6207.Capr-12-0250  0.32
2013 Bao Y, Giovannucci EL, Kraft P, Stampfer MJ, Ogino S, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, Rifai N, Pollak MN, Cochrane BB, Kaklamani V, Lin JH, et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. Journal of the National Cancer Institute. 105: 95-103. PMID 23243202 DOI: 10.1093/Jnci/Djs474  0.36
2013 Dallal CM, Brinton LA, Bauer DC, Buist DS, Cauley JA, Hue TF, Lacroix A, Tice JA, Chia VM, Falk R, Pfeiffer R, Pollak M, Veenstra TD, Xu X, Lacey JV, et al. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocrine-Related Cancer. 20: 151-60. PMID 23222000 DOI: 10.1530/Erc-12-0229  0.32
2012 Rice MS, Tworoger SS, Rosner BA, Pollak MN, Hankinson SE, Tamimi RM. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies. Breast Cancer Research and Treatment. 136: 805-12. PMID 23085768 DOI: 10.1007/s10549-012-2303-2  0.32
2012 Birmann BM, Neuhouser ML, Rosner B, Albanes D, Buring JE, Giles GG, Lan Q, Lee IM, Purdue MP, Rothman N, Severi G, Yuan JM, Anderson KC, Pollak M, Rifai N, et al. Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood. 120: 4929-37. PMID 23074271 DOI: 10.1182/Blood-2012-03-417253  0.32
2012 Javeshghani S, Zakikhani M, Austin S, Bazile M, Blouin MJ, Topisirovic I, St-Pierre J, Pollak MN. Carbon source and myc expression influence the antiproliferative actions of metformin. Cancer Research. 72: 6257-67. PMID 23041548 DOI: 10.1158/0008-5472.CAN-12-2907  0.32
2012 Hofmann JN, Liao LM, Pollak MN, Wang Y, Pfeiffer RM, Baris D, Andreotti G, Lan Q, Landgren O, Rothman N, Purdue MP. A prospective study of circulating adipokine levels and risk of multiple myeloma. Blood. 120: 4418-20. PMID 23007407 DOI: 10.1182/Blood-2012-06-438606  0.32
2012 Runchey SS, Pollak MN, Valsta LM, Coronado GD, Schwarz Y, Breymeyer KL, Wang C, Wang CY, Lampe JW, Neuhouser ML. Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study. European Journal of Clinical Nutrition. 66: 1146-52. PMID 22892437 DOI: 10.1038/Ejcn.2012.107  0.32
2012 Hvid H, Fendt SM, Blouin MJ, Birman E, Voisin G, Svendsen AM, Frank R, Vander Heiden MG, Stephanopoulos G, Hansen BF, Pollak M. Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway. Endocrine-Related Cancer. 19: 557-74. PMID 22685267 DOI: 10.1530/Erc-12-0125  0.32
2012 Colquhoun AJ, Venier NA, Vandersluis AD, Besla R, Sugar LM, Kiss A, Fleshner NE, Pollak M, Klotz LH, Venkateswaran V. Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. Prostate Cancer and Prostatic Diseases. 15: 346-52. PMID 22614062 DOI: 10.1038/Pcan.2012.16  0.32
2012 Jenkins CR, Shevchuk OO, Giambra V, Lam SH, Carboni JM, Gottardis MM, Holzenberger M, Pollak M, Humphries RK, Weng AP. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Experimental Hematology. 40: 715-723.e6. PMID 22613471 DOI: 10.1016/J.Exphem.2012.05.003  0.32
2012 Larsson O, Morita M, Topisirovic I, Alain T, Blouin MJ, Pollak M, Sonenberg N. Distinct perturbation of the translatome by the antidiabetic drug metformin. Proceedings of the National Academy of Sciences of the United States of America. 109: 8977-82. PMID 22611195 DOI: 10.1073/Pnas.1201689109  0.32
2012 Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, Fels D, Dewhirst MW, Dyck JR, Nagendran J, Flores CT, Betof AS, Nelson ER, Pollak M, Dash RC, Young ME, et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. Journal of Applied Physiology (Bethesda, Md. : 1985). 113: 263-72. PMID 22604887 DOI: 10.1152/Japplphysiol.01575.2011  0.32
2012 Rajpathak SN, He M, Sun Q, Kaplan RC, Muzumdar R, Rohan TE, Gunter MJ, Pollak M, Kim M, Pessin JE, Beasley J, Wylie-Rosett J, Hu FB, Strickler HD. Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes. 61: 2248-54. PMID 22554827 DOI: 10.2337/Db11-1488  0.32
2012 Chi KN, Gleave ME, Fazli L, Goldenberg SL, So A, Kollmannsberger C, Murray N, Tinker A, Pollak M. A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer Clinical Cancer Research. 18: 3407-3413. PMID 22553344 DOI: 10.1158/1078-0432.CCR-12-0482  0.32
2012 Kaplan RC, Bùzková P, Cappola AR, Strickler HD, McGinn AP, Mercer LD, Arnold AM, Pollak MN, Newman AB. Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study. The Journal of Clinical Endocrinology and Metabolism. 97: 1970-6. PMID 22442270 DOI: 10.1210/Jc.2011-2967  0.32
2012 Rice MS, Tamimi RM, Connolly JL, Collins LC, Shen D, Pollak MN, Rosner B, Hankinson SE, Tworoger SS. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II. Breast Cancer Research : Bcr. 14: R44. PMID 22414675 DOI: 10.1186/bcr3141  0.32
2012 Ollberding NJ, Cheng I, Wilkens LR, Henderson BE, Pollak MN, Kolonel LN, Le Marchand L. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 810-20. PMID 22354904 DOI: 10.1158/1055-9965.Epi-11-1105  0.44
2012 Algire C, Moiseeva O, Deschênes-Simard X, Amrein L, Petruccelli L, Birman E, Viollet B, Ferbeyre G, Pollak MN. Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prevention Research (Philadelphia, Pa.). 5: 536-43. PMID 22262811 DOI: 10.1158/1940-6207.Capr-11-0536  0.32
2012 Gao Y, Katki H, Graubard B, Pollak M, Martin M, Tao Y, Schoen RE, Church T, Hayes RB, Greene MH, Berndt SI. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. International Journal of Cancer. Journal International Du Cancer. 131: E105-13. PMID 21932422 DOI: 10.1002/Ijc.26438  0.32
2012 Tognon CE, Martin MJ, Moradian A, Trigo G, Rotblat B, Cheng SW, Pollard M, Uy E, Chow C, Carboni JM, Gottardis MM, Pollak M, Morin GB, Sorensen PH. A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation. Oncogene. 31: 1334-40. PMID 21804605 DOI: 10.1038/Onc.2011.323  0.32
2012 Zhang X, Giovannucci E, Wu K, Gao X, Hu F, Ogino S, Schernhammer E, Fuchs C, Pollak M, Willett W, Ma J. Abstract LB-323: Self-reported sleep duration and subsequent risk of colorectal cancer in two large cohorts of women and men Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-323  0.36
2011 Wu K, Feskanich D, Fuchs CS, Chan AT, Willett WC, Hollis BW, Pollak MN, Giovannucci E. Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. Plos One. 6: e28520. PMID 22216097 DOI: 10.1371/Journal.Pone.0028520  0.36
2011 Dool CJ, Mashhedi H, Zakikhani M, David S, Zhao Y, Birman E, Carboni JM, Gottardis M, Blouin MJ, Pollak M. IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer. Endocrine-Related Cancer. 18: 699-709. PMID 21946410 DOI: 10.1530/Erc-11-0136  0.32
2011 Pritchard KI, Shepherd LE, Chapman JA, Norris BD, Cantin J, Goss PE, Dent SF, Walde D, Vandenberg TA, Findlay B, O'Reilly SE, Wilson CF, Han L, Piura E, Whelan TJ, ... Pollak MN, et al. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3869-76. PMID 21911723 DOI: 10.1200/JCO.2010.33.7006  0.32
2011 Lipton A, Chapman JA, Demers L, Shepherd LE, Han L, Wilson CF, Pritchard KI, Leitzel KE, Ali SM, Pollak M. Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3605-10. PMID 21859992 DOI: 10.1200/Jco.2010.31.5069  0.32
2011 Mashhedi H, Blouin MJ, Zakikhani M, David S, Zhao Y, Bazile M, Birman E, Algire C, Aliaga A, Bedell BJ, Pollak M. Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet. Cell Cycle (Georgetown, Tex.). 10: 2770-8. PMID 21811094 DOI: 10.4161/Cc.10.16.16219  0.32
2011 Lubik AA, Gunter JH, Hendy SC, Locke JA, Adomat HH, Thompson V, Herington A, Gleave ME, Pollak M, Nelson CC. Insulin increases de novo steroidogenesis in prostate cancer cells. Cancer Research. 71: 5754-64. PMID 21747118 DOI: 10.1158/0008-5472.Can-10-2470  0.32
2011 Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, Hollis BW, Pollak MN, Fuchs CS. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1599-606. PMID 21422438 DOI: 10.1200/Jco.2010.31.7255  0.32
2011 Kaplan RC, Petersen AK, Chen MH, Teumer A, Glazer NL, Döring A, Lam CS, Friedrich N, Newman A, Müller M, Yang Q, Homuth G, Cappola A, Klopp N, Smith H, ... ... Pollak MN, et al. A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Human Molecular Genetics. 20: 1241-51. PMID 21216879 DOI: 10.1093/Hmg/Ddq560  0.32
2011 Gualberto A, Hixon ML, Karp DD, Li D, Green S, Dolled-Filhart M, Paz-Ares LG, Novello S, Blakely J, Langer CJ, Pollak MN. Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab. British Journal of Cancer. 104: 68-74. PMID 21102589 DOI: 10.1038/sj.bjc.6605972  0.32
2011 Takahara K, Tearle H, Ghaffari M, Gleave ME, Pollak M, Cox ME. Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression Prostate. 71: 525-537. PMID 20878948 DOI: 10.1002/Pros.21268  0.32
2011 Nimptsch K, Platz EA, Pollak MN, Kenfield SA, Stampfer MJ, Willett WC, Giovannucci E. Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004. International Journal of Cancer. Journal International Du Cancer. 128: 660-7. PMID 20473871 DOI: 10.1002/Ijc.25381  0.32
2011 Gualberto A, Hixon ML, Pollak M. Reply: Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab British Journal of Cancer. 105: 1467. DOI: 10.1038/bjc.2011.413  0.32
2010 Grimaldi-Bensouda L, Marty M, Pollak M, Cameron D, Riddle M, Charbonnel B, Barnett AH, Boffetta P, Boivin JF, Evans M, Rossignol M, Benichou J, Abenhaim L. The international study of insulin and cancer. Lancet (London, England). 376: 769-70. PMID 20816540 DOI: 10.1016/S0140-6736(10)61374-8  0.32
2010 Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2298-306. PMID 20699371 DOI: 10.1158/1055-9965.Epi-10-0400  0.32
2010 Furic L, Rong L, Larsson O, Koumakpayi IH, Yoshida K, Brueschke A, Petroulakis E, Robichaud N, Pollak M, Gaboury LA, Pandolfi PP, Saad F, Sonenberg N. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 107: 14134-9. PMID 20679199 DOI: 10.1073/Pnas.1005320107  0.32
2010 Canzian F, Cox DG, Setiawan VW, Stram DO, Ziegler RG, Dossus L, Beckmann L, Blanché H, Barricarte A, Berg CD, Bingham S, Buring J, Buys SS, Calle EE, Chanock SJ, ... ... Pollak M, et al. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Human Molecular Genetics. 19: 3873-84. PMID 20634197 DOI: 10.1093/Hmg/Ddq291  0.44
2010 Inoue T, Zakikhani M, David S, Algire C, Blouin MJ, Pollak M. Effects of castration on insulin levels and glucose tolerance in the mouse differ from those in man. The Prostate. 70: 1628-35. PMID 20564323 DOI: 10.1002/Pros.21198  0.32
2010 Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, et al. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Human Molecular Genetics. 19: 3089-101. PMID 20484221 DOI: 10.1093/Hmg/Ddq210  0.32
2010 Neuhouser ML, Till C, Kristal A, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M. Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Prevention Research (Philadelphia, Pa.). 3: 279-89. PMID 20179296 DOI: 10.1158/1940-6207.Capr-09-0188  0.32
2010 Gill JK, Wilkens LR, Pollak MN, Stanczyk FZ, Kolonel LN. Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort. The Prostate. 70: 906-15. PMID 20166103 DOI: 10.1002/pros.21125  0.32
2010 Mucci LA, Stark JR, Pollak MN, Li H, Kurth T, Stampfer MJ, Ma J. Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 484-91. PMID 20142246 DOI: 10.1158/1055-9965.EPI-09-0836  0.32
2010 Zakikhani M, Blouin MJ, Piura E, Pollak MN. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Research and Treatment. 123: 271-9. PMID 20135346 DOI: 10.1007/s10549-010-0763-9  0.32
2010 Khalid S, Hwang D, Babichev Y, Kolli R, Altamentova S, Koren S, Goodwin PJ, Ennis M, Pollak M, Sonenberg N, Fantus IG. Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis. Breast Cancer Research and Treatment. 122: 647-59. PMID 19851863 DOI: 10.1007/S10549-009-0586-8  0.32
2010 Tsilidis KK, Brancati FL, Pollak MN, Rifai N, Clipp SL, Hoffman-Bolton J, Helzlsouer KJ, Platz EA. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes & Control : Ccc. 21: 1-10. PMID 19774471 DOI: 10.1007/S10552-009-9428-6  0.32
2010 Blouin MJ, Zhao Y, Zakikhani M, Algire C, Piura E, Pollak M. Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose. Cancer Letters. 289: 246-53. PMID 19744772 DOI: 10.1016/J.Canlet.2009.08.021  0.32
2010 Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. International Journal of Cancer. Journal International Du Cancer. 126: 180-90. PMID 19551864 DOI: 10.1002/Ijc.24674  0.32
2009 Pollak MN, Blouin M, Zakikhani M, Zhao Y, Algire C. Dependence of malignant proliferation associated with loss of PTEN on glucose concentration in the hyperglycemic range: Relevance to population studies linking hyperglycemia to unfavorable cancer prognosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11113. PMID 27963493 DOI: 10.1200/jco.2009.27.15_suppl.11113  0.56
2009 Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, et al. Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 4: 1397-403. PMID 19745765 DOI: 10.1097/JTO.0b013e3181ba2f1d  0.32
2009 Dowling RJ, Pollak M, Sonenberg N. Current status and challenges associated with targeting mTOR for cancer therapy. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 23: 77-91. PMID 19489650 DOI: 10.2165/00063030-200923020-00002  0.32
2009 Mavropoulos JC, Buschemeyer WC, Tewari AK, Rokhfeld D, Pollak M, Zhao Y, Febbo PG, Cohen P, Hwang D, Devi G, Demark-Wahnefried W, Westman EC, Peterson BL, Pizzo SV, Freedland SJ. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prevention Research (Philadelphia, Pa.). 2: 557-65. PMID 19470786 DOI: 10.1158/1940-6207.Capr-08-0188  0.32
2009 Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G, Rifai N, Pollak MN, Agurs-Collins T, Platz EA. Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1484-91. PMID 19423525 DOI: 10.1158/1055-9965.Epi-08-0817  0.32
2009 Kaplan RC, Fitzpatrick AL, Pollak MN, Gardner JP, Jenny NS, McGinn AP, Kuller LH, Strickler HD, Kimura M, Psaty BM, Aviv A. Insulin-like growth factors and leukocyte telomere length: the cardiovascular health study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 64: 1103-6. PMID 19349587 DOI: 10.1093/Gerona/Glp036  0.32
2009 Okereke OI, Selkoe DJ, Pollak MN, Stampfer MJ, Hu FB, Hankinson SE, Grodstein F. A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation. International Journal of Geriatric Psychiatry. 24: 177-82. PMID 18612998 DOI: 10.1002/gps.2089  0.32
2008 Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prevention Research (Philadelphia, Pa.). 1: 369-75. PMID 19138981 DOI: 10.1158/1940-6207.Capr-08-0081  0.32
2008 Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE, Nicholson RI, Carboni J, Gottardis M, Pollak M, Dunn SE. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Research. 68: 10238-46. PMID 19074892 DOI: 10.1158/0008-5472.Can-08-2755  0.32
2008 Fuchs CS, Goldberg RM, Sargent DJ, Meyerhardt JA, Wolpin BM, Green EM, Pitot HC, Pollak M. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 8263-9. PMID 19073970 DOI: 10.1158/1078-0432.Ccr-08-0480  0.32
2008 Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes. Breast Cancer Research : Bcr. 10: R86. PMID 18925950 DOI: 10.1186/Bcr2156  0.32
2008 Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV, Helzlsouer K, Rinaldi S, Riboli E, ... ... Pollak M, et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Annals of Internal Medicine. 149: 461-71, W83-8. PMID 18838726 DOI: 10.7326/0003-4819-149-7-200810070-00006  0.32
2008 Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. The Prostate. 68: 1477-86. PMID 18618736 DOI: 10.1002/Pros.20819  0.32
2008 Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Cox DG, Dorronsoro M, Dossus L, Haiman CA, Hankinson SE, ... ... Pollak M, et al. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). Plos One. 3: e2578. PMID 18596909 DOI: 10.1371/Journal.Pone.0002578  0.32
2008 Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM. High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. American Heart Journal. 155: 1006-12. PMID 18513511 DOI: 10.1016/J.Ahj.2007.12.031  0.32
2008 Algire C, Zakikhani M, Blouin MJ, Shuai JH, Pollak M. Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth. Endocrine-Related Cancer. 15: 833-9. PMID 18469156 DOI: 10.1677/Erc-08-0038  0.32
2008 Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X, Ho GYF, Einstein MH, Kaplan RC, Burk RD, Wylie-Rosett J, Pollak MN, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer Cancer Epidemiology Biomarkers and Prevention. 17: 921-929. PMID 18398032 DOI: 10.1158/1055-9965.Epi-07-2686  0.32
2008 Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E. Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes & Control : Ccc. 19: 703-10. PMID 18340542 DOI: 10.1007/S10552-008-9133-X  0.32
2008 Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. Journal of the American Geriatrics Society. 56: 652-60. PMID 18312313 DOI: 10.1111/J.1532-5415.2007.01637.X  0.32
2008 Okereke OI, Pollak MN, Hu FB, Hankinson SE, Selkoe DJ, Grodstein F. Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes. Psychoneuroendocrinology. 33: 455-61. PMID 18261857 DOI: 10.1016/j.psyneuen.2008.01.002  0.32
2008 Rajpathak SN, McGinn AP, Strickler HD, Rohan TE, Pollak M, Cappola AR, Kuller L, Xue X, Newman AB, Strotmeyer ES, Psaty BM, Kaplan RC. Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 18: 166-73. PMID 17904401 DOI: 10.1016/J.Ghir.2007.08.004  0.32
2007 Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Research. 67: 11083-91. PMID 18006855 DOI: 10.1158/0008-5472.Can-07-2222  0.32
2007 Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Research. 67: 10804-12. PMID 18006825 DOI: 10.1158/0008-5472.Can-07-2310  0.32
2007 Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft. Carcinogenesis. 28: 2567-74. PMID 17916909 DOI: 10.1093/Carcin/Bgm218  0.32
2007 Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Jing M, Fuchs CS. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women Cancer Epidemiology Biomarkers and Prevention. 16: 2101-2109. PMID 17905943 DOI: 10.1158/1055-9965.Epi-07-0182  0.32
2007 Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Research. 67: 7923-8. PMID 17699799 DOI: 10.1158/0008-5472.Can-07-0373  0.32
2007 Levitt RJ, Zhao Y, Blouin MJ, Pollak M. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells. Cancer Letters. 255: 300-6. PMID 17602833 DOI: 10.1016/J.Canlet.2007.05.006  0.32
2007 Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts British Journal of Cancer. 97: 98-104. PMID 17533398 DOI: 10.1038/Sj.Bjc.6603826  0.32
2007 Schaffer A, Koushik A, Trottier H, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Pollak MN, Franco EL. Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 716-22. PMID 17416762 DOI: 10.1158/1055-9965.Epi-06-0924  0.44
2007 McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Pollak M, Tao Y, Helzlsouer KJ. C-reactive protein concentrations and subsequent ovarian cancer risk. Obstetrics and Gynecology. 109: 933-41. PMID 17400857 DOI: 10.1097/01.Aog.0000257126.68803.03  0.32
2007 Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I, Freedman ML, Hankinson SE, Hunter DJ, Colditz GA. Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Research : Bcr. 9: R18. PMID 17300730 DOI: 10.1186/Bcr1655  0.32
2007 Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. The Journal of Clinical Endocrinology and Metabolism. 92: 1319-25. PMID 17264182 DOI: 10.1210/Jc.2006-1631  0.32
2006 Tran CD, Diorio C, Bérubé S, Pollak M, Brisson J. Relation of insulin-like growth factor (IGF) I and IGF-binding protein 3 concentrations with intakes of fruit, vegetables, and antioxidants. The American Journal of Clinical Nutrition. 84: 1518-26. PMID 17158438 DOI: 10.1093/Ajcn/84.6.1518  0.32
2006 Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Research. 66: 10269-73. PMID 17062558 DOI: 10.1158/0008-5472.Can-06-1500  0.32
2006 Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1977-83. PMID 17035408 DOI: 10.1158/1055-9965.Epi-06-0477  0.32
2006 Tseng PH, Wang YC, Weng SC, Weng JR, Chen CS, Brueggemeier RW, Shapiro CL, Chen CY, Dunn SE, Pollak M, Chen CS. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. Molecular Pharmacology. 70: 1534-41. PMID 16887935 DOI: 10.1124/Mol.106.023911  0.32
2006 Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 972-8. PMID 16702379 DOI: 10.1158/1055-9965.Epi-05-0848  0.32
2006 Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer. Gynecologic Oncology. 100: 389-96. PMID 16300820 DOI: 10.1016/j.ygyno.2005.09.048  0.32
2006 Rousseau MC, Parent ME, Pollak MN, Siemiatycki J. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. International Journal of Cancer. Journal International Du Cancer. 118: 2105-9. PMID 16284945 DOI: 10.1002/Ijc.21600  0.32
2006 Rollison DE, Newschaffer CJ, Tao Y, Pollak M, Helzlsouer KJ. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. International Journal of Cancer. Journal International Du Cancer. 118: 1279-84. PMID 16161053 DOI: 10.1002/Ijc.21471  0.32
2005 Kucab JE, Lee C, Chen CS, Zhu J, Gilks CB, Cheang M, Huntsman D, Yorida E, Emerman J, Pollak M, Dunn SE. Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours. Breast Cancer Research : Bcr. 7: R796-807. PMID 16168126 DOI: 10.1186/Bcr1294  0.32
2005 Platz EA, Pollak MN, Leitzmann MF, Stampfer MJ, Willett WC, Giovannucci E. Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era Cancer Causes and Control. 16: 255-262. PMID 15947877 DOI: 10.1007/S10552-004-3484-8  0.32
2005 Meyerhardt JA, Sloan JA, Sargent DJ, Goldberg RM, Pollak M, Morton RF, Ramanathan RK, Williamson SK, Findlay BP, Fuchs CS. Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1402-10. PMID 15941948 DOI: 10.1158/1055-9965.Epi-04-0862  0.32
2005 Majeed N, Blouin MJ, Kaplan-Lefko PJ, Barry-Shaw J, Greenberg NM, Gaudreau P, Bismar TA, Pollak M. A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene. 24: 4736-40. PMID 15870705 DOI: 10.1038/Sj.Onc.1208572  0.32
2005 Sutherland BW, Kucab J, Wu J, Lee C, Cheang MC, Yorida E, Turbin D, Dedhar S, Nelson C, Pollak M, Leighton Grimes H, Miller K, Badve S, Huntsman D, Blake-Gilks C, et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene. 24: 4281-92. PMID 15806160 DOI: 10.1038/Sj.Onc.1208590  0.32
2005 Kristal AR, King IB, Albanes D, Pollak MN, Stanzyk FZ, Santella RM, Hoque A. Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 727-30. PMID 15767358 DOI: 10.1158/1055-9965.EPI-04-0596  0.32
2004 Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche TJ, Pollak M. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression. Biochemical and Biophysical Research Communications. 316: 421-8. PMID 15020235 DOI: 10.1016/J.Bbrc.2004.02.062  0.32
2004 Labrie F, Champagne P, Labrie C, Roy J, Laverdière J, Provencher L, Potvin M, Drolet Y, Pollak M, Panasci L, L'Espérance B, Dufresne J, Latreille J, Robert J, Samson B, et al. Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer Journal of Clinical Oncology. 22: 864-871. PMID 14990642 DOI: 10.1200/Jco.2004.05.122  0.44
2004 Lu Y, Zi X, Zhao Y, Pollak M. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells. Biochemical and Biophysical Research Communications. 313: 709-15. PMID 14697248 DOI: 10.1016/J.Bbrc.2003.12.007  0.6
2004 Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. International Journal of Cancer. Journal International Du Cancer. 108: 773-9. PMID 14696106 DOI: 10.1002/Ijc.11624  0.32
2004 Lu Y, Zi X, Pollak M. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells. International Journal of Cancer. 108: 334-41. PMID 14648698 DOI: 10.1002/Ijc.11445  0.6
2003 Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN. Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. International Journal of Cancer. 107: 60-4. PMID 12925957 DOI: 10.1002/ijc.11358  0.32
2002 Camirand A, Lu Y, Pollak M. Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 8: BR521-6. PMID 12503030  0.6
2002 Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP. Effects of lycopene supplementation in patients with localized prostate cancer Experimental Biology and Medicine. 227: 881-885. PMID 12424329 DOI: 10.1177/153537020222701007  0.44
2002 Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE, Pollak MN, Hankinson SE. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer International Journal of Cancer. 100: 332-336. PMID 12115549 DOI: 10.1002/Ijc.10473  0.32
2001 Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). Journal of the National Cancer Institute. 93: 1852-7. PMID 11752009 DOI: 10.1093/Jnci/93.24.1852  0.6
2001 Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, Hudson T, Stampfer M, Pollak M. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. The Journal of Clinical Endocrinology and Metabolism. 86: 1274-1280. PMID 11238520 DOI: 10.1210/Jcem.86.3.7280  0.52
2001 Trojan DA, Collet J, Pollak MN, Shapiro S, Jubelt B, Miller RG, Agre JC, Munsat TL, Hollander D, Tandan R, Robinson A, Finch L, Ducruet T, Cashman NR. Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome. Journal of the Neurological Sciences. 182: 107-15. PMID 11137515 DOI: 10.1016/S0022-510X(00)00459-7  0.32
2000 Giovannucci E, Pollak M, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the nurses' health study Growth Hormone and Igf Research. 10. PMID 10984283 DOI: 10.1016/S1096-6374(00)90014-5  0.32
2000 Platz EA, Pollak MN, Willett WC, Giovannucci E. Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3 Journal of the American Academy of Dermatology. 42: 1003-1007. PMID 10827403 DOI: 10.1067/Mjd.2000.103987  0.32
2000 Foulkes WD, Chappuis PO, Wong N, Brunet JS, Vesprini D, Rozen F, Yuan ZQ, Pollak MN, Kuperstein G, Narod SA, Bégin LR. Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 11: 307-13. PMID 10811497 DOI: 10.1023/A:1008340723974  0.52
2000 Huynh H, Beamer W, Pollak M, Chan TWMG. Modulation of transforming growth factor beta1 gene expression in the mammary gland by insulin-like growth factor I and octreotide. International Journal of Oncology. 16: 277-358. PMID 10639570 DOI: 10.3892/Ijo.16.2.277  0.44
1999 Nickerson T, Pollak M. Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins Urology. 54: 1120-1125. PMID 10604720 DOI: 10.1016/S0090-4295(99)00421-5  0.48
1999 Rozen F, Pollak M. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells : A role for insulin-like growth factor binding proteins International Journal of Oncology. 15: 589-683. PMID 10427145 DOI: 10.3892/Ijo.15.3.589  0.52
1999 Nickerson T, Zhang J, Pollak M. Regression of DMBA-induced breast carcinoma following ovariectomy is associated with increased expression of genes encoding insulin-like growth factor binding proteins. International Journal of Oncology. 14: 987-1077. PMID 10200352 DOI: 10.3892/Ijo.14.5.987  0.52
1999 Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma Cancer. 85: 1284-1292. PMID 10189133 DOI: 10.1002/(SICI)1097-0142(19990315)85:6<1284::AID-CNCR10>3.0.CO;2-P  0.32
1998 Nickerson T, Pollak M, Huynh H. Castration-Induced Apoptosis in the Rat Ventral Prostate Is Associated with Increased Expression of Genes Encoding Insulin-Like Growth Factor Binding Proteins 2, 3, 4 and 5. Endocrinology. 139: 807-810. PMID 28200348 DOI: 10.1210/endo.139.2.5912  0.48
1998 Rozen F, Zhang J, Pollak M. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. International Journal of Oncology. 13: 865-874. PMID 9735418 DOI: 10.3892/Ijo.13.4.865  0.52
1998 Huynh H, Pollak M, Zhang JC. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089 International Journal of Oncology. 13: 137-143. PMID 9625815 DOI: 10.3892/Ijo.13.1.137  0.44
1998 Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer Lancet. 351: 1393-1396. PMID 9593409 DOI: 10.1016/S0140-6736(97)10384-1  0.32
1998 Nickerson T, Pollak M, Huynh H. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5 Endocrinology. 139: 807-810. PMID 9449659 DOI: 10.1210/Endo.139.2.5912  0.44
1997 Huynh H, Beamer WD, Pollak M. Overexpression of insulin-like growth factor binding protein 4 (IGFBP-4) in MCF-7 breast cancer cells is associated with reduced responsiveness to insulin-like growth factors in vitro and reduced tumour growth in vivo. International Journal of Oncology. 11: 193-197. PMID 21528201 DOI: 10.3892/Ijo.11.1.193  0.44
1997 Nickerson T, Huynh H, Pollak M. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells Biochemical and Biophysical Research Communications. 237: 690-693. PMID 9299428 DOI: 10.1006/Bbrc.1997.7089  0.44
1997 Karp SE, Tonin PN, Bégin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer. 80: 435-41. PMID 9241077 DOI: 10.1002/(Sici)1097-0142(19970801)80:3<435::Aid-Cncr11>3.0.Co;2-Y  0.44
1997 Rozen F, Yang X, Huynh H, Pollak M. Antiproliferative Action of Vitamin D-Related Compounds and Insulin-Like Growth Factor-Binding Protein 5 Accumulation Journal of the National Cancer Institute. 89: 652-656. PMID 9150190 DOI: 10.1093/Jnci/89.9.652  0.52
1996 Phelan CM, Larsson C, Baird S, Futreal PA, Ruttledge MH, Morgan K, Tonin P, Hung H, Korneluk RG, Pollak MN, Narod SA. The human mammary-derived growth inhibitor (MDGI) gene: Genomic structure and mutation analysis in human breast tumors Genomics. 34: 63-68. PMID 8661024 DOI: 10.1006/Geno.1996.0241  0.44
1996 Huynh H, Yang X, Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells Journal of Biological Chemistry. 271: 1016-1021. PMID 8557625 DOI: 10.1074/Jbc.271.2.1016  0.44
1995 Hung H, Pollak M. Regulation of IGFBP-3 expression in breast cancer cells and uterus by estradiol and antiestrogens: Correlations with effects on proliferation: A review Progress in Growth Factor Research. 6: 495-501. PMID 8817694 DOI: 10.1016/0955-2235(95)00036-4  0.44
1995 Huynh H, Pollak M. HH2A, an immortalized bovine mammary epithelial cell line, expresses the gene encoding mammary derived growth inhibitor (MDGI) In Vitro Cellular &Amp; Developmental Biology - Animal. 31: 25-29. PMID 7535635 DOI: 10.1007/Bf02631334  0.44
1994 Sekyi-Otu A, Bell R, Andrulis I, Pollak M. Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacement. Journal of the National Cancer Institute. 86: 628-32. PMID 8145278 DOI: 10.1093/Jnci/86.8.628  0.44
1994 Huynh H, Pollak M. Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue Biochemical and Biophysical Research Communications. 203: 253-259. PMID 8074663 DOI: 10.1006/Bbrc.1994.2175  0.44
1993 Tonin P, Ehrenborg E, Lenoir G, Feunteun J, Lynch H, Morgan K, Zazzi H, Vivier A, Pollak M, Huynh H, Luthman H, Larsson C, Narod S. The Human Insulin-like Growth Factor-Binding Protein 4 Gene Maps to Chromosome Region 17q12-q21.1 and Is Close to the Gene for Hereditary Breast-Ovarian Cancer Genomics. 18: 414-417. PMID 7507078 DOI: 10.1006/Geno.1993.1487  0.44
1992 Pollak MN, Huynh HT, Lefebvre SP. Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Research and Treatment. 22: 91-100. PMID 1421427 DOI: 10.1007/BF01833337  0.44
1992 Tannenbaum GS, Gurd W, Lapointe M, Pollak M. Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin. Endocrinology. 130: 3395-401. PMID 1350760 DOI: 10.1210/Endo.130.6.1350760  0.44
1990 Pollak M, Costantino J, Polychronakos C, Blauer SA, Guyda H, Redmond C, Fisher B, Margolese R. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients Journal of the National Cancer Institute. 82: 1693-1697. PMID 2231756 DOI: 10.1093/Jnci/82.21.1693  0.44
1988 Pollak MN, Polychronakos C, Yousefi S, Richard M. Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells Biochemical and Biophysical Research Communications. 154: 326-331. PMID 2969239 DOI: 10.1016/0006-291X(88)90688-2  0.44
1987 Filmus J, Trent JM, Pollak MN, Buick RN. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants Molecular and Cellular Biology. 7: 251-257. PMID 3494191 DOI: 10.1128/MCB.7.1.251  0.44
1987 Pollak MN, Perdue JF, Margolese RG, Baer K, Richard M. Presence of somatomedin receptors on primary human breast and colon carcinomas Cancer Letters. 38: 223-230. PMID 2961436 DOI: 10.1016/0304-3835(87)90218-7  0.44
1985 Filmus J, Pollak MN, Cairncross JG, Buick RN. Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line Biochemical and Biophysical Research Communications. 131: 207-215. PMID 2994648 DOI: 10.1016/0006-291X(85)91790-5  0.44
1985 Filmus J, Pollak MN, Cailleau R, Buick RN. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF Biochemical and Biophysical Research Communications. 128: 898-905. PMID 2986629 DOI: 10.1016/0006-291X(85)90131-7  0.44
Show low-probability matches.